Brokerages Set AdaptHealth Corp. (NASDAQ:AHCO) Target Price at $13.60

AdaptHealth Corp. (NASDAQ:AHCO) has received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $13.60.

A number of research firms have weighed in on AHCO. Canaccord Genuity Group boosted their target price on shares of AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Wall Street Zen cut AdaptHealth from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Weiss Ratings raised AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, December 29th. Finally, Zacks Research raised AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st.

Insider Activity

In other news, Director David Solomon Williams III sold 5,000 shares of AdaptHealth stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $9.43, for a total transaction of $47,150.00. Following the transaction, the director owned 45,045 shares in the company, valued at approximately $424,774.35. The trade was a 9.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.55% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. FNY Investment Advisers LLC bought a new stake in shares of AdaptHealth in the 3rd quarter valued at about $35,000. AlphaQuest LLC lifted its stake in shares of AdaptHealth by 275.7% in the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock worth $37,000 after acquiring an additional 2,892 shares during the period. Assetmark Inc. boosted its holdings in AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after acquiring an additional 2,581 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in AdaptHealth by 318.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after purchasing an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC bought a new position in AdaptHealth during the 2nd quarter worth approximately $96,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $10.49 on Tuesday. AdaptHealth has a twelve month low of $7.11 and a twelve month high of $11.63. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09. The stock’s 50-day simple moving average is $9.83 and its 200 day simple moving average is $9.44. The firm has a market capitalization of $1.42 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 1.19 and a beta of 1.71.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 4th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). The company had revenue of $820.31 million during the quarter, compared to the consensus estimate of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The firm’s revenue was up 1.8% compared to the same quarter last year. During the same period last year, the company posted $0.15 EPS. On average, analysts anticipate that AdaptHealth will post 0.88 EPS for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.